Pharmaceutical
INVENTA commercializes specialty pharmaceutical portfolios in Bangladesh — from oncology and immunology to biosimilars and critical care injectables — under full MAH compliance, scientific medical affairs, and GSDP distribution.
MAH
Compliant
DGDA
Registered
50+
Specialty Lines
GSDP
Cold Chain
Therapeutic Portfolio
Oncology, Immunology & Critical Care
Oncology & Hematology
Targeted therapies, cytotoxics, and supportive care portfolios commercialized with evidence-based medical affairs and hospital access programs.
Immunology & Biosimilars
Biologics and biosimilar portfolios launched with pharmacovigilance rigor, cold-chain logistics, and specialist physician engagement.
Critical Care & Hospital Injectables
ICU, anesthesia, and emergency injectables supplied to tertiary hospitals with uninterrupted availability and regulatory documentation.
Commercialization Pillars
Sector 01
Specialty Care
5 product linesHigh-complexity molecules requiring scientific positioning and specialist access.
- 01Oncology
- 02Immunology
- 03Rheumatology
- 04Dermatology
- 05Rare Disease
Sector 02
Hospital & Institutional
5 product linesFormulary listing, tenders, and contract supply for public and private hospitals.
- 01Government Tenders
- 02ICU Formularies
- 03CSSD Supply
- 04OTC Hospital Channels
- 05NGO Programs
Sector 03
Regulatory Backbone
5 product linesEvery product marketed under Inventa's registered MAH and DGDA compliance framework.
- 01MAH Registration
- 02CTD Dossiers
- 03Pharmacovigilance
- 04Import Licenses
- 05Price Certification
Discuss your pharmaceutical requirements
Partner with Inventa for MAH-compliant specialty commercialization, hospital access, and scientific market development.
Contact Our Team